Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Cong Fei"'
Autor:
Congying Xie, Sandra Chica Duque, Cong Fei, Chen Ling, Yong Liu, Philippe Merle, Zhenggang Ren, Xikun Wu, Helena Verdaguer Mata, Yee Chao, Richard A Hubner, Ying Cheng, Zhirong Shen, Bai Li, Jane Margetts, Ruiqi Huang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundTislelizumab, an anti-PD-1 monoclonal antibody, demonstrated clinical activity and was well-tolerated in patients with previously treated advanced hepatocellular carcinoma (HCC) in the Phase 2 RATIONALE-208 study (NCT03419897). We explored
Autor:
Pei Zhang, Zhirong Shen, Yuk Ting Ma, Ruiqi Huang, Bai Li, Gianluca Masi, Julien Edeline, Sandra Chica Duque, Xikun Wu, Zhiqiang Meng, Chen Ling, Cong Fei, Weilin Wang, Chiun Hsu, Xiaopeng Ma, Henning Wege
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A387-A387
BackgroundTislelizumab, an anti-programmed cell death protein-1 monoclonal antibody, demonstrated clinical activity and was well tolerated in patients with previously treated advanced HCC in the open-label, multicenter, Phase 2 RATIONALE-208 study (N